VYR-206
Neurological Disorders (Diagnostic)
Pre-clinicalActive
Key Facts
Indication
Neurological Disorders (Diagnostic)
Phase
Pre-clinical
Status
Active
Company
About Vyripharm Biopharmaceuticals
Vyripharm Biopharmaceuticals is a private, pre-revenue biotech company founded in 2015, operating from the Texas Medical Center in Houston. The company is developing a novel, integrated theranostic platform (BioSync™) that combines diagnostics and therapeutics, with applications in oncology, viral infections like COVID-19, and neurological disorders. Its strategy involves building global partnerships and leveraging AI, but it faces significant risks as an early-stage company with a broad, complex pipeline and unproven technology. Key leadership includes individuals with backgrounds in academia, business development, and medicine.
View full company profile